Cell-mediated immunity in invasive cervical carcinoma associated with human papillomavirus types 16 and 18 infection.
Park
T K
TK
Kim
S N
SN
Lee
C H
CH
D016516:CD4-CD8 Ratio; D002277:Carcinoma / Q000276:immunology* / Q000821:virology*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D027383:Papillomaviridae / Q000145:classification*; D030361:Papillomavirus Infections / Q000150:complications* / Q000821:virology; D012703:Serotyping; D014412:Tumor Virus Infections / Q000150:complications* / Q000821:virology; D002577:Uterine Cervical Diseases / Q000150:complications* / Q000821:virology; D002583:Uterine Cervical Neoplasms / Q000276:immunology* / Q000821:virology*